J. Kotzan

发表

Differential Attitudes Toward an Adult Education Program for Pharmacists

J. Kotzan, A. W. Jowdy, 1970 .

Responsiveness of Drug Store Sales to Shelf Space Allocations

J. Kotzan, R. V. Evanson, Jeffrey A. Kotzan, 1969 .

In vitro and in vivo bioequivalence of commerical prednisone tablets

I. L. Honigberg, V. Shah, J. Kotzan, 1984 .

Development and Implementation of a Factor-Analyzed Faculty Evaluation Instrument for Undergraduate Pharmacy Instruction.

J. Kotzan, D. N. Entrekin, 1978 .

Persistence with Estrogen Therapy in a Postmenopausal Medicaid Population

B. Martin, J. Kotzan, W. Wade, 1999, Pharmacotherapy.

The impact of race and fractures on mortality in a postmenopausal Medicaid population.

J. Reeves, B. Martin, J. Kotzan, 1999, Clinical therapeutics.

In vitro and in vivo bioequivalence of commercial prednisone tablets.

I. L. Honigberg, V. Shah, J. Kotzan, 1984, Biopharmaceutics & drug disposition.

Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients.

J. Kotzan, N. Carroll, L. Kotzan, 1989, American journal of hospital pharmacy.

Effect of obtrusive measures on antibiotic compliance.

J. Kotzan, R. Hunter, 1979, Journal of pharmaceutical sciences.

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

I. L. Honigberg, J. Vallner, J. Kotzan, 1981, Journal of clinical pharmacology.

Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tablet.

I. L. Honigberg, V. Shah, J. Gallo, 1990, Biopharmaceutics & drug disposition.

Correlation of aspirin excretion with parameters from different dissolution methods.

H. Zia, T. Needham, J. Kotzan, 1978, Journal of pharmaceutical sciences.

Assessing NSAID Prescription Use as a Predisposing Factor for Gastroesophageal Reflux Disease in a Medicaid Population

J. Kotzan, W. Wade, Hsin-Hui Yu, 2001, Pharmaceutical Research.

The Effectiveness of Auxiliary Prescription Labels: A Pilot Study

J. Kotzan, J. Cooper, J. Wiederholt, 1983, Drug intelligence & clinical pharmacy.

Significant Factors for Predicting Academic Success of First-Year Pharmacy Students

Henry H. Cobb, J. Kotzan, M. Chisholm, 1995, American Journal of Pharmaceutical Education.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

B. Martin, J. Kotzan, R. Ganguly, 2004, The Journal of clinical psychiatry.

Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort.

B. Martin, M. Gottlieb, J. Kotzan, 2002, Clinical therapeutics.

Bioequivalency and dose proportionality of three tableted promethazine products.

I. L. Honigberg, V. Shah, J. Kotzan, 1986, Biopharmaceutics & drug disposition.

Formulary Management of Low Molecular Weight Heparins

B. Martin, M. Perri, J. Kotzan, 2012, PharmacoEconomics.

An in Vivo Single- and Multiple-Dose Study of Several Marketed Brands of Conventional and Controlled-Release Theophylline

I. L. Honigberg, J. Kotzan, J. T. Stewart, 1984, Drug intelligence & clinical pharmacy.

Prior Four Year College Degree and Academic Performance of First Year Pharmacy Students: A Three Year Study

G. Lautenschlager, J. Kotzan, M. Chisholm, 1997 .

Validity comparison of PCAT and SAT in the prediction of first-year GPA.

J. Kotzan, D. N. Entrekin, 1977, American journal of pharmaceutical education.

The Prescription to Nonprescription Switch: Consumer Awareness, Purchases, Information Sources and the Pharmacist

M. Perri, J. Fincham, J. Kotzan, 1987 .

OBRA '90: the impact on pharmacists and patients.

M. Perri, J. Kotzan, L. Pritchard, 1995, American pharmacy.

Isolating the Cost of Osteoporosis-Related Fracture for Postmenopausal Women

B. Martin, J. Kotzan, M. Chisholm, 2001, Gerontology.

A Multivariate Analysis of Retail Prescription Prices

J. Kotzan, C. Braucher, 1970 .

Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts

B. Martin, J. Kotzan, L. Miller, 2001, Schizophrenia Research.

An analysis of the adequacy of medicaid prescriptions.

J. Kotzan, D. A. Riley, C. Braucher, 1973, Journal of the American Pharmaceutical Association.

Effectiveness of the FDA-Designed Patient Package Insert for Benzodiazepines

J. Kotzan, J. Wiederholt, 1983 .

Plasma Levels of Clobazam after 10‐, 20‐, and 40‐mg Tablet Doses in Healthy Subjects

I. L. Honigberg, T. Needham, J. Vallner, 1980, Journal of clinical pharmacology.

Examination of blood clobazam levels and several pupillary measures in humans.

I. L. Honigberg, T. Needham, J. Vallner, 1979, Journal of Pharmacy and Science.

Plasma Levels of Clobazam After Three Oral Dosage Forms in Healthy Subjects

T. Needham, J. Kotzan, J. T. Stewart, 1978, Journal of clinical pharmacology.

Pharmacy-veterinary medicine.

J. Kotzan, D. N. Entrekin, E. D. Sumner, 1975, Journal of the American Pharmaceutical Association.

A proposed general protocol for testing bioequivalence of controlled-release drug products

I. L. Honigberg, J. Vallner, J. Kotzan, 1983 .

Effect of diazepam on cognition via pupillometry.

J. Kotzan, 1978, Journal of pharmaceutical sciences.